Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
Taiwan · Delayed Price · Currency is TWD 154.00
+2.00 (1.32%)
Feb 11, 2026, 1:30 PM CST
TPEX:6712 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 520.9 | 367.25 | 539.4 | 200.71 | 369.6 | -106.83 |
Depreciation & Amortization | 25.05 | 30.49 | 31.8 | 34.73 | 35.14 | 31.26 |
Other Amortization | 0.37 | 0.4 | 0.51 | 0.82 | 0.68 | 0.67 |
Loss (Gain) From Sale of Assets | 0.01 | 0.01 | - | 0 | -11.33 | 0.05 |
Loss (Gain) From Sale of Investments | -66.04 | 46.68 | -241.86 | 22.7 | -261.05 | -14.31 |
Loss (Gain) on Equity Investments | -49.19 | -52.09 | - | - | - | - |
Stock-Based Compensation | 46.8 | - | - | 0.79 | 2.14 | 4.22 |
Other Operating Activities | -22.19 | 69.34 | 63.59 | 32.04 | 26.66 | -30.4 |
Change in Accounts Receivable | -0.78 | -93.36 | -16.94 | -51.1 | -17.62 | -9.66 |
Change in Inventory | 23.63 | -10.95 | 19.22 | -31.53 | -21.28 | -20.73 |
Change in Accounts Payable | -9.28 | 1.8 | -5.74 | 14.08 | 9.96 | 3.88 |
Change in Unearned Revenue | 104.28 | 72.48 | 31.76 | 77.68 | 8.09 | 1.64 |
Change in Other Net Operating Assets | 15.66 | 8.29 | 0.01 | 18.27 | -5.29 | 1.74 |
Operating Cash Flow | 589.22 | 440.34 | 421.74 | 319.2 | 135.69 | -138.47 |
Operating Cash Flow Growth | 41.33% | 4.41% | 32.12% | 135.25% | - | - |
Capital Expenditures | -1.5 | -4.85 | -5.82 | -3.19 | -1.98 | -58.83 |
Sale of Property, Plant & Equipment | - | - | - | - | 28.1 | 0.07 |
Sale (Purchase) of Intangibles | -4.41 | -0.71 | -0.02 | -2.41 | -2.67 | -1.97 |
Investment in Securities | -60.08 | 22.76 | 64.31 | -279.19 | -316.21 | 216 |
Other Investing Activities | -16.84 | -40.67 | 3.12 | -2.52 | -4.06 | -8.5 |
Investing Cash Flow | -82.83 | -23.46 | 61.6 | -287.31 | -296.83 | 146.77 |
Long-Term Debt Repaid | - | -11.59 | -11.92 | -11.11 | -10.02 | -8.96 |
Net Debt Issued (Repaid) | -10.91 | -11.59 | -11.92 | -11.11 | -10.02 | -8.96 |
Issuance of Common Stock | 0.28 | 0.02 | 4.04 | 2.37 | 745.29 | 37.46 |
Repurchase of Common Stock | -349.42 | - | -356.35 | - | - | - |
Common Dividends Paid | -407.8 | -440.03 | -136.29 | -309.49 | - | - |
Other Financing Activities | 17.54 | -0.04 | 0.06 | -1.2 | -1.9 | 0.09 |
Financing Cash Flow | -750.3 | -451.64 | -500.47 | -319.43 | 733.36 | 28.59 |
Net Cash Flow | -243.91 | -34.77 | -17.13 | -287.53 | 572.22 | 36.89 |
Free Cash Flow | 587.72 | 435.49 | 415.92 | 316.02 | 133.7 | -197.3 |
Free Cash Flow Growth | 42.79% | 4.70% | 31.61% | 136.35% | - | - |
Free Cash Flow Margin | 58.42% | 46.63% | 54.84% | 50.36% | 30.47% | -279.48% |
Free Cash Flow Per Share | 6.66 | 4.91 | 4.61 | 3.46 | 1.47 | -2.40 |
Cash Interest Paid | 0.77 | 0.13 | 0.2 | 0.51 | 0.62 | 0.78 |
Cash Income Tax Paid | 119.03 | 68.57 | 19.66 | 31.17 | 0.04 | -0 |
Levered Free Cash Flow | 444.55 | 290.39 | 304.48 | 219.61 | 100.32 | -148.09 |
Unlevered Free Cash Flow | 445.04 | 290.47 | 304.6 | 219.92 | 100.7 | -147.6 |
Change in Working Capital | 133.52 | -21.74 | 28.3 | 27.4 | -26.15 | -23.12 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.